FROM: U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION
Puerto Rico has lower rates of new cases of lung and breast cancer than the rest of US
Puerto Rico has the lowest incidence rate of new lung cancer compared with all other races and ethnic groups in the United States, according to a study published today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report. The report also shows that Puerto Rico has a lower incidence rate of female breast cancer compared with U.S. non-Hispanic white and black women.
The report presents for the first time invasive cancer incidence rates for 2007–2011 among Puerto Rican residents by sex, age, cancer site, and region using U.S. Cancer Statistics data. Puerto Rico has similar incidence rates to U.S. populations for cancer of the colon and rectum. Cancers of the prostate (152 cases per 100,000 men), female breast (84 cases per 100,000 women), and colon and rectum (43 cases per 100,000 persons) are the most common cancer sites among Puerto Rico residents.
"These data underscore the importance of Puerto Ricans getting proper screening for breast, cervical, and colorectal cancer to identify them early when they are most treatable," said Guillermo Tortolero-Luna, M.D., Ph.D., director of Cancer Control and Populations Sciences at the University of Puerto Rico and a co-author of the paper.
The differences in reported cancer incidence rates between U.S. and Puerto Rican residents may be partly explained by differences in health behaviors and risk factors associated with cancers. For example, Puerto Rico has lower smoking rates than all American states (with the exception of Utah), which could explain the lower rates of lung cancer.
"We are encouraged to see lower lung cancer incidence rates in Puerto Rico than the rest of the U.S. However, we must remain diligent in our cancer control efforts to continue progress," said Blythe Ryerson, Ph.D., M.P.H., a lead epidemiologist in CDC's Division of Cancer Prevention and Control and an author of the paper. "We recommend all smokers quit for good."
Showing posts with label LUNG CANCER. Show all posts
Showing posts with label LUNG CANCER. Show all posts
Friday, April 17, 2015
Friday, January 10, 2014
CDC SAYS LUNG CANCER NEW CASES DECREASED FROM 2005-2009
FROM: CENTERS FOR DISEASE CONTROL AND PREVENTION
Rates of new lung cancer cases drop in U.S. men and women
CDC report finds fastest drop in adults aged 35-44 years
Tobacco control efforts are having a major impact on Americans’ health, a new analysis of lung-cancer data suggests. The rate of new lung cancer cases decreased among men and women in the United States from 2005 to 2009, according to a report in this week’s Morbidity and Mortality Weekly Report.
The study also found that lung cancer incidence rates went down 2.6 percent per year among men, from 87 to 78 cases per 100,000 men and 1.1 percent per year among women, from 57 to 54 cases per 100,000 women.
The fastest drop was among adults aged 35-44 years, decreasing 6.5 percent per year among men and 5.8 percent per year among women. Lung cancer incidence rates decreased more rapidly among men than among women in all age groups. Among adults aged 35-44 years, men had slightly lower rates of lung cancer incidence than women.
“These dramatic declines in the number of young adults with lung cancer show that tobacco prevention and control programs work – when they are applied,” said CDC Director Tom Frieden, M.D., M.P.H.
Lung cancer is the leading cause of cancer death and the second most commonly diagnosed cancer among both men and women in the United States. Most lung cancers are attributable to cigarette smoking and secondhand smoke. Because smoking behaviors among women are now similar to those among men, women are now experiencing the same risk of lung cancer as men.
“While it is encouraging that lung cancer incidence rates are dropping in the United States, one preventable cancer is one too many,” Dr. Frieden said. “Implementation of tobacco control strategies is needed to reduce smoking prevalence and the lung cancer it causes among men and women.”
In 2010, states appropriated only 2.4 percent of their tobacco revenues for tobacco control. An earlier CDC study showed that states vary widely in their success at reducing smoking – and in reducing new lung cancers.
In the new report, CDC used data from the National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End ResultsExternal Web Site Icon program for the period 2005–2009 to assess lung cancer incidence rates and trends among men and women by age group.
Lung cancer incidence decreased among men in all U.S. Census regions and 23 states, and decreased among women in the South and West and seven states. Rates were stable in all other states. These declines reflect the successes of past tobacco prevention and control efforts.
The study indicates that continued attention to local, state, and national population-based tobacco prevention and control strategies are needed to achieve further reductions in smoking prevalence among both men and women of all ages to reduce subsequent lung cancer in the United States. Strategies proven to reduce tobacco use among youth and adults include increased tobacco prices, comprehensive smoke-free laws, restriction of tobacco advertising and promotion, and hard-hitting mass media and community engagement campaigns.
This month marks the 50th anniversary of the first Surgeon General's Report linking cigarette smoking to lung cancer. Smoking remains the leading cause of preventable death and disease in the United States. Millions of Americans are living with a smoking-related disease, and each day more than 2,100 youth and young adults become daily smokers.
Through the Affordable Care Act, more Americans will qualify to get health care coverage that fits their needs and budget, including important preventive services such as tobacco use screenings and tobacco cessation services that may be covered with no additional costs.
Rates of new lung cancer cases drop in U.S. men and women
CDC report finds fastest drop in adults aged 35-44 years
Tobacco control efforts are having a major impact on Americans’ health, a new analysis of lung-cancer data suggests. The rate of new lung cancer cases decreased among men and women in the United States from 2005 to 2009, according to a report in this week’s Morbidity and Mortality Weekly Report.
The study also found that lung cancer incidence rates went down 2.6 percent per year among men, from 87 to 78 cases per 100,000 men and 1.1 percent per year among women, from 57 to 54 cases per 100,000 women.
The fastest drop was among adults aged 35-44 years, decreasing 6.5 percent per year among men and 5.8 percent per year among women. Lung cancer incidence rates decreased more rapidly among men than among women in all age groups. Among adults aged 35-44 years, men had slightly lower rates of lung cancer incidence than women.
“These dramatic declines in the number of young adults with lung cancer show that tobacco prevention and control programs work – when they are applied,” said CDC Director Tom Frieden, M.D., M.P.H.
Lung cancer is the leading cause of cancer death and the second most commonly diagnosed cancer among both men and women in the United States. Most lung cancers are attributable to cigarette smoking and secondhand smoke. Because smoking behaviors among women are now similar to those among men, women are now experiencing the same risk of lung cancer as men.
“While it is encouraging that lung cancer incidence rates are dropping in the United States, one preventable cancer is one too many,” Dr. Frieden said. “Implementation of tobacco control strategies is needed to reduce smoking prevalence and the lung cancer it causes among men and women.”
In 2010, states appropriated only 2.4 percent of their tobacco revenues for tobacco control. An earlier CDC study showed that states vary widely in their success at reducing smoking – and in reducing new lung cancers.
In the new report, CDC used data from the National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End ResultsExternal Web Site Icon program for the period 2005–2009 to assess lung cancer incidence rates and trends among men and women by age group.
Lung cancer incidence decreased among men in all U.S. Census regions and 23 states, and decreased among women in the South and West and seven states. Rates were stable in all other states. These declines reflect the successes of past tobacco prevention and control efforts.
The study indicates that continued attention to local, state, and national population-based tobacco prevention and control strategies are needed to achieve further reductions in smoking prevalence among both men and women of all ages to reduce subsequent lung cancer in the United States. Strategies proven to reduce tobacco use among youth and adults include increased tobacco prices, comprehensive smoke-free laws, restriction of tobacco advertising and promotion, and hard-hitting mass media and community engagement campaigns.
This month marks the 50th anniversary of the first Surgeon General's Report linking cigarette smoking to lung cancer. Smoking remains the leading cause of preventable death and disease in the United States. Millions of Americans are living with a smoking-related disease, and each day more than 2,100 youth and young adults become daily smokers.
Through the Affordable Care Act, more Americans will qualify to get health care coverage that fits their needs and budget, including important preventive services such as tobacco use screenings and tobacco cessation services that may be covered with no additional costs.
Friday, August 16, 2013
VA HAS IDENTIFIED RESPIRATORY CANCERS ASSOCIATED WITH AGENT ORANGE
FROM: U.S. DEPARTMENT OF VETERANS AFFAIRS
Veterans' Diseases Associated with Agent Orange » Respiratory Cancers
Veterans who develop respiratory cancer (lung, bronchus, larynx, or trachea) and
were exposed to Agent Orange or other herbicides during military service do not have to prove a connection between their disease and service to be eligible to receive VA health care and disability compensation.
About respiratory cancers
Respiratory cancers are cancers of the lung, larynx, trachea, and bronchus.
Symptoms vary, depending on the location of the cancer:
Lung cancer—a new cough or cough that doesn't go away, coughing up blood, shortness of breath, chest pain, hoarseness
Cancer of the trachea—dry cough, hoarseness, breathlessness, difficulty swallowing
Cancer of the larynx (at the top of the trachea)—hoarseness, voice changes, sore throat or earache, feeling of a lump in the throat
Cancer of the bronchus—cough, chest pain, coughing blood
Visit Medline Plus to learn more about treatment of cancer and the latest research from the National Institutes of Health.
Guard against lung cancer
Number one rule: Don’t smoke and avoid second-hand smoke. VA can help you every step of the way to quit smoking.
VA benefits for respiratory cancers
Veterans with respiratory cancers (lung, bronchus, larynx, or trachea) who were exposed to Agent Orange or other herbicides during service may be eligible for disability compensation and health care.
Veterans who served in Vietnam, the Korean demilitarized zone or another area where Agent Orange was sprayed may be eligible for an Agent Orange Registry health exam, a free, comprehensive examination.
Surviving spouses, dependent children and dependent parents of Veterans who were exposed to herbicides during military service and died as the result of respiratory cancers may be eligible for survivors' benefits.
Research on respiratory cancers and herbicides used in Vietnam
The Institute of Medicine (IOM) of the National Academy of Sciences concluded in its 1994 report "Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam" and in future updates that there is limited/suggestive evidence of an association between exposure to herbicides (2,4-D; 2,4,5-T and its contaminant TCDD; cacodylic acid; and picloram) and respiratory cancers.
In updates to this report, IOM noted that associations linking development of respiratory cancers and exposure to dioxin were found consistently only when herbicide exposures appeared to be high and prolonged.
Veterans' Diseases Associated with Agent Orange » Respiratory Cancers
Veterans who develop respiratory cancer (lung, bronchus, larynx, or trachea) and
were exposed to Agent Orange or other herbicides during military service do not have to prove a connection between their disease and service to be eligible to receive VA health care and disability compensation.
About respiratory cancers
Respiratory cancers are cancers of the lung, larynx, trachea, and bronchus.
Symptoms vary, depending on the location of the cancer:
Lung cancer—a new cough or cough that doesn't go away, coughing up blood, shortness of breath, chest pain, hoarseness
Cancer of the trachea—dry cough, hoarseness, breathlessness, difficulty swallowing
Cancer of the larynx (at the top of the trachea)—hoarseness, voice changes, sore throat or earache, feeling of a lump in the throat
Cancer of the bronchus—cough, chest pain, coughing blood
Visit Medline Plus to learn more about treatment of cancer and the latest research from the National Institutes of Health.
Guard against lung cancer
Number one rule: Don’t smoke and avoid second-hand smoke. VA can help you every step of the way to quit smoking.
VA benefits for respiratory cancers
Veterans with respiratory cancers (lung, bronchus, larynx, or trachea) who were exposed to Agent Orange or other herbicides during service may be eligible for disability compensation and health care.
Veterans who served in Vietnam, the Korean demilitarized zone or another area where Agent Orange was sprayed may be eligible for an Agent Orange Registry health exam, a free, comprehensive examination.
Surviving spouses, dependent children and dependent parents of Veterans who were exposed to herbicides during military service and died as the result of respiratory cancers may be eligible for survivors' benefits.
Research on respiratory cancers and herbicides used in Vietnam
The Institute of Medicine (IOM) of the National Academy of Sciences concluded in its 1994 report "Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam" and in future updates that there is limited/suggestive evidence of an association between exposure to herbicides (2,4-D; 2,4,5-T and its contaminant TCDD; cacodylic acid; and picloram) and respiratory cancers.
In updates to this report, IOM noted that associations linking development of respiratory cancers and exposure to dioxin were found consistently only when herbicide exposures appeared to be high and prolonged.
Subscribe to:
Posts (Atom)